Exemestane ( Aromasin )
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Exemestane ( Aromasin ), covering 2012-09-14 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery [Phase 2]